HOSPITAL UNIVERSITARIO RUBER
Département
University of Montpellier
Montpellier, FranciaPublications en collaboration avec des chercheurs de University of Montpellier (1)
2021
-
Phase III randomized study of taselisib or placebo with fulvestrant in estrogen receptor-positive, PIK3CA-mutant, HER2-negative, advanced breast cancer: the SANDPIPER trial
Annals of Oncology, Vol. 32, Núm. 2, pp. 197-207